Agenus (AGEN) Revenue Growth (3y) (2013 - 2026)
Agenus (AGEN) Revenue Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,132.22 Bn | 67,131.94 Bn | - | - |
| 2 | Nanobiotix | 1,910.87 Bn | 1,910.81 Bn | - | - |
| 3 | Akari Therapeutics | 989.71 Bn | 989.71 Bn | - | - |
| 4 | BeOne Medicines | 471.60 Bn | 466.80 Bn | 1.35 Bn | 50.07% |
| 5 | Vertex Pharmaceuticals | 121.71 Bn | 114.46 Bn | 2.59 Bn | 7.94% |
| 6 | Regeneron Pharmaceuticals | 69.83 Bn | 61.07 Bn | 3.31 Bn | 4.47% |
| 7 | Belite Bio | 62.74 Bn | 62.74 Bn | - | - |
| 8 | Argenx Se | 55.83 Bn | 50.65 Bn | 1.41 Bn | 79.44% |
| 9 | Alnylam Pharmaceuticals | 37.33 Bn | 34.32 Bn | 959.66 Mn | 54.05% |
| 10 | Agenus | 232.20 Mn | 197.20 Mn | 33.74 Mn | 13.78% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 13.78% |
| Dec 31, 2025 | 40.47% |
| Sep 30, 2025 | 9.91% |
| Jun 30, 2025 | 7.08% |
| Mar 31, 2025 | -2.47% |
| Dec 31, 2024 | 9.82% |
| Sep 30, 2024 | -53.70% |
| Jun 30, 2024 | 29.88% |
| Mar 31, 2024 | 33.69% |
| Dec 31, 2023 | 38.91% |
| Sep 30, 2023 | 17.91% |
| Jun 30, 2023 | -2.08% |
| Mar 31, 2023 | 14.82% |
| Dec 31, 2022 | -48.66% |
| Sep 30, 2022 | 4.53% |
| Jun 30, 2022 | 10.02% |
| Mar 31, 2022 | -31.27% |
| Dec 31, 2021 | 46.45% |
| Sep 30, 2021 | 170.35% |
| Jun 30, 2021 | -12.28% |